Nithya Agrawal

3PUBLICATIONS
16CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 16, 2026
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.

|May 16, 2024
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results.

Jorge E Cortes, Koji Sasaki, Dong-Wook Kim

|Mar 23, 2023
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results.

Michael J Mauro, Timothy P Hughes, Dong-Wook Kim

Pageof 1

Frequent Collaborators

3 joint publications

Michael J Mauro

3 joint publications

Jorge E Cortes

3 joint publications

Andreas Hochhaus

3 joint publications

Massimo Breccia

3 joint publications

Yeow-Tee Goh

3 joint publications

Daniel J DeAngelo

3 joint publications

Michael C Heinrich

2 joint publications

Koji Sasaki

2 joint publications

Michael Deininger

2 joint publications

Timothy P Hughes

Frequent Collaborators

3 joint publications

Michael J Mauro

3 joint publications

Jorge E Cortes

3 joint publications

Andreas Hochhaus

3 joint publications

Massimo Breccia

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us